BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6181279)

  • 21. Secretion of soluble VEGF receptor 2 by microvascular endothelial cells derived by human benign prostatic hyperplasia.
    Stachon A; Aweimer A; Stachon T; Tannapfel A; Thoms S; Ubrig B; Köller M; Krieg M; Truss MC
    Growth Factors; 2009 Apr; 27(2):71-8. PubMed ID: 19199116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
    Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
    Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid hormone--related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells.
    Cramer SD; Peehl DM; Edgar MG; Wong ST; Deftos LJ; Feldman D
    Prostate; 1996 Jul; 29(1):20-9. PubMed ID: 8685051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
    Bonkhoff H; Remberger K
    Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pigment epithelium-derived factor, a human testis epididymis secretory product, promotes human prostate stromal cell growth in culture.
    Grayhack JT; Smith ND; Ilio K; Wambi C; Kasjanski R; Crawford SE; Doll JA; Wang Z; Lee C; Kozlowski JM
    J Urol; 2004 Jan; 171(1):434-8. PubMed ID: 14665949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia.
    Claus S; Berges R; Senge T; Schulze H
    J Urol; 1997 Jul; 158(1):217-21. PubMed ID: 9186363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro cultivation of prostatic epithelium.
    Stone KR; Stone MP; Paulson DF
    Invest Urol; 1976 Jul; 14(1):79-82. PubMed ID: 60304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostate-specific antigen in serum and prostate epithelium in benign prostatic hyperplasia].
    Papava VL; Kochiashvili DK; Chovelidze ShG; Khardzeishvili OM
    Georgian Med News; 2007 Feb; (143):73-6. PubMed ID: 17404446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.
    Orgad U; Alroy J; Ucci A; Merk FB
    Lab Invest; 1984 Mar; 50(3):294-302. PubMed ID: 6199584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infrared microspectroscopic detection of epithelial and stromal growth in the human benign prostatic hyperplasia.
    Li MJ; Hsu HS; Liang RC; Lin SY
    Ultrastruct Pathol; 2002; 26(6):365-70. PubMed ID: 12537761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructural and biophysical studies on protein conformations of epithelium and stroma in benign prostatic hyperplasia before and after transurethral resection of the prostate.
    Hsu HS; Lin SY; Li MJ; Liang RC
    Ultrastruct Pathol; 2002; 26(3):137-41. PubMed ID: 12184371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long-term administration of androgens and estrogen on rhesus monkey prostate: possible induction of benign prostatic hyperplasia.
    Jeyaraj DA; Udayakumar TS; Rajalakshmi M; Pal PC; Sharma RS
    J Androl; 2000; 21(6):833-41. PubMed ID: 11105909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].
    Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM
    Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic and immunologic studies of human prostatic carcinoma.
    Mickey DD; Stone KR; Stone MP; Paulson DF
    Cancer Treat Rep; 1977; 61(2):133-8. PubMed ID: 68819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.